Pharmacosmos works closely and actively with our partners around the world for the marketing of our IV iron products. We believe that the combination of our partners' local expertise within Sales, Marketing and Market Access combined with Pharmacosmos' deep knowledge of the international market for IV iron and the treatment of Iron Deficiency, is the foundation for a successful business and a solid long-term business relationship. Key words in the relationships with our partners are dedication, professionalism, long term relationships and mutual respect and understanding.
Apart from our partners being professional and competent within the marketing of ethical pharmaceutical products, we ask our partners to be dedicated to making Monofer a success in a close cooperation with Pharmacosmos, which entail that sufficient dedicated resources are assigned to the Monofer® business. Furthermore, the partner should have existing business in some of the relevant segments, typically gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.
A future business partner for a market can obtain the exclusive license for a number of years for marketing of Monofer, and a potential partner must master:
If you are interested in becoming one of our successful business partners, please submit basic info to us as per below list:
To learn more, please contact Lars Ploug Hansen at firstname.lastname@example.org
We are looking to in-license complementary specialty care products within gastroenterology, nephrology, gyn/obs, surgery and cardiovascular diseases. We are seeking pan-EU rights or alternatively rights to the Nordic countries, Germany, Ireland, and/or the UK.
Our focus is on complex and innovative products with IP protection and a scientific content in either late development, in filing phase, or already approved.
To learn more, please contact Michael Ryde at email@example.com
We collaborate with leading medical experts in driving research to uncover new clinical insights of iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans. We are actively seeking opportunities to collaborate on investigator sponsored studies.
To learn more, please contact Lars L. Thomsen at firstname.lastname@example.org
You are now leaving Pharmacosmos.com. The website you are about to visit is a Pharmacosmos subsidary.
Do you wish to proceed?